Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with <i>NF1</i> point variants.
Where this comes from
- Record sourced from PubMed, PMID 40759488.
- Also identified by DOI 10.1136/jmg-2025-110783 and PMC identifier 12703300.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders. NF1 is caused by dominant loss-of-function pathogenic variants (PVs) of the tumour-suppressor gene <i>NF1</i>, which encodes neurofibromin, a negative regulator of rat sarcoma proteins. NF1 is an autosomal dominant disorder with complete penetrance, but a highly variable expression. Identification of genotype-phenotype correlations is challenging because of the wide clinical variability, the progressive nature of the disorder and the extreme diversity of the mutation spectrum. Only a few <i>NF1</i> point variants have been associated with a specific phenotype in NF1 patients. We investigated a large, well-phenotyped NF1 cohort. We report analyses of genotype-phenotype correlations in 112 NF1 patients with specific <i>NF1</i> point variants: p.Arg1809 missense variants were associated with a mild form of NF1 (n=24), while a more severe phenotype was associated with codons 844-848 (n=27), p.Arg1276 (n=25) and p.Lys1423 (n=35) missense variants. We describe a new correlation for p.Arg1204 missense variants (n=11), with no neurofibroma observed in patients. Functional studies will be critical for drawing conclusions on the potential hypomorphic or dominant-negative effects of these variants. The current data confirms several genotype-phenotype correlations in NF1, which may be relevant to the management and surveillance of NF1 patients with specific <i>NF1</i> PVs.
Medical subject headings
- Neurofibromatosis 1
- Neurofibromin 1
- Genetic Association Studies
- Point Mutation